Cheminformatics Analysis of Assertions Mined from Literature That Describe Drug-Induced Liver Injury in Different Species

Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 c...

Full description

Saved in:
Bibliographic Details
Published inChemical research in toxicology Vol. 23; no. 1; pp. 171 - 183
Main Authors Fourches, Denis, Barnes, Julie C, Day, Nicola C, Bradley, Paul, Reed, Jane Z, Tropsha, Alexander
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 01.01.2010
Subjects
Online AccessGet full text
ISSN0893-228X
1520-5010
1520-5010
DOI10.1021/tx900326k

Cover

Abstract Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39−44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds’ chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure−activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.
AbstractList Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39-44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds' chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure-activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.
Drug Induced Liver Injury (DILI) is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structure is critical to help guiding experimental drug discovery projects towards safer medicines. In this study, we have compiled a dataset of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and non-rodents. The liver effects for this dataset were obtained as assertional meta-data, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this dataset using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39–44%) between different species raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion re-generation from MEDLINE, as well as other data sources. In some cases, additional biological assertions were identified which were in line with expectations based on compounds' chemical similarity. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs. no liver effect), and binary QSAR models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external five-fold cross validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.
Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39-44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds' chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure-activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39-44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds' chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure-activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.
Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39−44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds’ chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure−activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.
Author Tropsha, Alexander
Bradley, Paul
Barnes, Julie C
Fourches, Denis
Day, Nicola C
Reed, Jane Z
AuthorAffiliation 2 BioWisdom Ltd, Harston Mill, Harston, Cambridge, CB22 7GG, U.K
1 Laboratory for Molecular Modeling, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill NC 27599, USA
AuthorAffiliation_xml – name: 2 BioWisdom Ltd, Harston Mill, Harston, Cambridge, CB22 7GG, U.K
– name: 1 Laboratory for Molecular Modeling, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill NC 27599, USA
Author_xml – sequence: 1
  givenname: Denis
  surname: Fourches
  fullname: Fourches, Denis
– sequence: 2
  givenname: Julie C
  surname: Barnes
  fullname: Barnes, Julie C
– sequence: 3
  givenname: Nicola C
  surname: Day
  fullname: Day, Nicola C
– sequence: 4
  givenname: Paul
  surname: Bradley
  fullname: Bradley, Paul
– sequence: 5
  givenname: Jane Z
  surname: Reed
  fullname: Reed, Jane Z
– sequence: 6
  givenname: Alexander
  surname: Tropsha
  fullname: Tropsha, Alexander
  email: alex_tropsha@unc.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20014752$$D View this record in MEDLINE/PubMed
BookMark eNptkU1vEzEQhi1URNPCgT-AfEGIw1J_7Nq7F6Qo4SNSEAeKxM1yvOPGYddObW9F_j2uUiJAPc1I88w7H-8FOvPBA0IvKXlHCaNX-VdHCGfi5xM0ow0jVUMoOUMz0na8Yqz9cY4uUtoRQgsun6FzVtJaNmyGDostjM7bEEednUl47vVwSC7hYPE8JYjZBZ_wF-ehxzaGEa9dhqjzFAFfb3XGS0gmug3gZZxuqpXvJ1PQtbuDiFd-N8UDdh4vnbUQwWf8bQ_GQXqOnlo9JHjxEC_R948frhefq_XXT6vFfF1pLrpcSS3bum7rzlDWG0G7VsjayI4I0fGNbY2UwkLLNTFy05OGCcaM6HpTLqyt6fglen_U3U-bEXpTVoh6UPvoRh0PKmin_q14t1U34U6xtryRsiLw5kEghtsJUlajSwaGQXsIU1KS85Y0vK4L-ervUacZf95dgLdHwMSQUgR7QihR91aqk5WFvfqPNS7rezfKlm54tOP1sUObpHZhisXK9Aj3G4kmrjo
CitedBy_id crossref_primary_10_1111_j_1747_0285_2012_01411_x
crossref_primary_10_1080_08927022_2024_2365377
crossref_primary_10_1007_s11224_012_0195_8
crossref_primary_10_1016_j_compbiomed_2013_11_013
crossref_primary_10_1007_s11030_012_9364_3
crossref_primary_10_1080_00268976_2024_2353331
crossref_primary_10_1093_toxsci_kfaa005
crossref_primary_10_1021_nn1013484
crossref_primary_10_1021_ci100176x
crossref_primary_10_1186_1471_2105_12_112
crossref_primary_10_1177_02698811231187127
crossref_primary_10_4018_IJQSPR_2018010101
crossref_primary_10_1016_j_crtox_2023_100108
crossref_primary_10_1021_acs_chemrestox_0c00423
crossref_primary_10_30699_ijmm_18_3_135
crossref_primary_10_1186_s12910_015_0024_x
crossref_primary_10_1038_nrgastro_2011_22
crossref_primary_10_1186_s12967_019_1976_2
crossref_primary_10_1039_C7RA12957B
crossref_primary_10_1016_j_heliyon_2023_e21894
crossref_primary_10_1051_bioconf_202413501004
crossref_primary_10_3390_microorganisms11061608
crossref_primary_10_1016_j_jhazmat_2022_129193
crossref_primary_10_4155_fmc_10_194
crossref_primary_10_1021_acs_chemrestox_4c00015
crossref_primary_10_1021_acs_chemrestox_8b00054
crossref_primary_10_3389_fphar_2016_00442
crossref_primary_10_1002_minf_201100005
crossref_primary_10_1021_acs_jmedchem_5b00104
crossref_primary_10_1021_acs_molpharmaceut_8b01048
crossref_primary_10_1021_ci400460q
crossref_primary_10_1038_srep46277
crossref_primary_10_1002_minf_201600143
crossref_primary_10_1038_s41598_025_86016_9
crossref_primary_10_3390_ijtm3020013
crossref_primary_10_1021_ci300146h
crossref_primary_10_1021_ci300421n
crossref_primary_10_2217_pme_11_89
crossref_primary_10_1016_j_comtox_2020_100133
crossref_primary_10_1002_minf_201500055
crossref_primary_10_1021_tx100412m
crossref_primary_10_1002_jat_2879
crossref_primary_10_1080_00268976_2024_2436095
crossref_primary_10_3109_17435390_2015_1073397
crossref_primary_10_1515_zpch_2023_0397
crossref_primary_10_1021_acs_chemrev_6b00851
crossref_primary_10_1371_journal_pcbi_1002310
crossref_primary_10_1007_s10822_011_9468_3
crossref_primary_10_1124_dmd_118_083055
crossref_primary_10_1517_17425255_2012_648613
crossref_primary_10_1140_epjp_s13360_024_05900_x
crossref_primary_10_1111_bph_13207
crossref_primary_10_1007_s10822_016_9972_6
crossref_primary_10_1177_026119291604400407
crossref_primary_10_1016_j_ijbiomac_2025_141273
crossref_primary_10_1177_026119291504300112
crossref_primary_10_1186_s13321_017_0230_2
crossref_primary_10_1002_minf_201200119
crossref_primary_10_1186_1479_5876_10_217
crossref_primary_10_1080_17425255_2017_1316449
crossref_primary_10_1021_acs_molpharmaceut_5b00583
crossref_primary_10_1021_acs_jcim_3c00200
crossref_primary_10_1016_j_tox_2017_06_003
crossref_primary_10_1016_j_compchemeng_2025_109066
crossref_primary_10_1016_j_drudis_2011_05_007
crossref_primary_10_1016_j_jhazmat_2024_134297
crossref_primary_10_1007_s40203_025_00324_6
crossref_primary_10_1002_minf_201400188
crossref_primary_10_1021_acs_jcim_6b00277
crossref_primary_10_1177_15353702231209421
crossref_primary_10_1007_s10989_016_9564_2
crossref_primary_10_3390_ijms20081897
crossref_primary_10_1111_cbdd_14607
crossref_primary_10_3109_10408444_2013_811215
crossref_primary_10_1186_1472_6939_13_16
crossref_primary_10_1021_ci300367a
crossref_primary_10_1007_s00204_015_1618_2
crossref_primary_10_1080_1062936X_2016_1264468
crossref_primary_10_1093_toxsci_kfx099
crossref_primary_10_1016_j_vascn_2013_12_003
crossref_primary_10_1155_2021_2293871
crossref_primary_10_3390_molecules25030481
crossref_primary_10_1002_wcms_100
crossref_primary_10_1177_026119291304100504
crossref_primary_10_3109_03602532_2011_605791
crossref_primary_10_1016_j_chphi_2024_100784
crossref_primary_10_1039_c3ra40787j
crossref_primary_10_1016_j_comtox_2021_100187
crossref_primary_10_1002_minf_201000061
crossref_primary_10_1039_D0CS00098A
crossref_primary_10_1124_dmd_110_035113
crossref_primary_10_1016_j_tox_2014_03_009
crossref_primary_10_1177_1535370214531872
crossref_primary_10_1080_1062936X_2016_1201142
crossref_primary_10_2217_bmm_13_146
crossref_primary_10_1177_026119291404200306
crossref_primary_10_1155_2020_4795140
crossref_primary_10_1126_scitranslmed_3000890
crossref_primary_10_1021_acs_chemrestox_5b00465
crossref_primary_10_1080_10406638_2023_2239984
crossref_primary_10_1002_adfm_201909553
Cites_doi 10.1016/S0168-8278(97)80494-1
10.1006/rtph.2000.1399
10.1016/j.taap.2008.01.037
10.2174/138620708785739907
10.1016/j.cbpa.2006.06.023
10.1016/S0378-4274(98)00261-6
10.1016/j.ddtec.2004.11.002
10.1093/toxsci/kfn109
10.1021/ci700443v
10.2174/138161207782794257
10.1021/tx600260a
10.1016/j.jmgm.2004.03.009
10.1007/978-1-4757-3264-1
10.1007/s10822-005-9008-0
10.1002/qsar.200810084
10.2174/1389200053586118
10.1023/B:JCAM.0000021834.50768.c6
10.1021/ci800151m
10.1177/009286150103500134
10.1016/j.toxlet.2008.09.017
10.1086/381446
10.2174/157340908785747465
10.1002/jcc.20812
10.1080/07366290601067481
10.1002/hep.21095
10.1007/s00204-006-0091-3
ContentType Journal Article
Copyright Copyright © 2009 American Chemical Society
Copyright_xml – notice: Copyright © 2009 American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1021/tx900326k
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Cheminformatics Analysis of Assertions Mined from Literature
EISSN 1520-5010
EndPage 183
ExternalDocumentID PMC2850112
20014752
10_1021_tx900326k
d083852940
Genre Research Support, U.S. Gov't, Non-P.H.S
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: R21 GM076059
– fundername: NIGMS NIH HHS
  grantid: R21GM076059
GroupedDBID -
29B
4.4
55A
5GY
5RE
5VS
7~N
AABXI
ABFLS
ABMVS
ABPTK
ABUCX
ACGFS
ACJ
ACS
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
CS3
EBS
ED
ED~
EJD
F5P
GNL
IH9
IHE
JG
JG~
LG6
P2P
ROL
TN5
UI2
UPT
VF5
VG9
W1F
X
YZZ
---
-~X
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ADHLV
AGXLV
AHGAQ
CITATION
CUPRZ
GGK
.GJ
.HR
1WB
53G
ABHMW
ACRPL
ADNMO
AEYZD
AGQPQ
ANPPW
ANTXH
CGR
CUY
CVF
ECM
EIF
NPM
RNS
ZGI
7X8
5PM
ID FETCH-LOGICAL-a369t-7a7844849c12dc6198674c7906693bf8c776fe83a0c7bd052622c69dc0144fc93
IEDL.DBID ACS
ISSN 0893-228X
1520-5010
IngestDate Thu Aug 21 13:56:10 EDT 2025
Wed Oct 01 17:19:30 EDT 2025
Mon Jul 21 06:01:19 EDT 2025
Tue Jul 01 03:45:16 EDT 2025
Thu Apr 24 22:51:24 EDT 2025
Thu Aug 27 13:41:55 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a369t-7a7844849c12dc6198674c7906693bf8c776fe83a0c7bd052622c69dc0144fc93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 20014752
PQID 733805344
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2850112
proquest_miscellaneous_733805344
pubmed_primary_20014752
crossref_primary_10_1021_tx900326k
crossref_citationtrail_10_1021_tx900326k
acs_journals_10_1021_tx900326k
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
ACJ
VG9
W1F
ACS
AEESW
AFEFF
ABMVS
ABUCX
IH9
BAANH
AQSVZ
ED~
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-01-01
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – month: 01
  year: 2010
  text: 2010-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Chemical research in toxicology
PublicationTitleAlternate Chem. Res. Toxicol
PublicationYear 2010
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References Farkas D. (ref8/cit8) 2005; 6
Sutter W. (ref7/cit7) 2006; 10
Elferink M. G. (ref12/cit12) 2008; 229
O’Brien P. J. (ref4/cit4) 2006; 80
Olson H. (ref28/cit28) 2000; 32
Egan W. (ref3/cit3) 2004; 1
Olson H. (ref27/cit27) 1998; 102
Varnek D. (ref19/cit19) 2006; 19
Varnek A. (ref24/cit24) 2007; 25
ref23/cit23
Zhu H. (ref32/cit32) 2008; 48
Olson H. (ref17/cit17) 2000; 32
Varnek A. (ref20/cit20) 2008; 4
Cruz-Monteagudo M. (ref16/cit16) 2008; 29
Ballet F. (ref6/cit6) 1997; 26
Xu J. J. (ref10/cit10) 2008; 105
Kaplowitz N. (ref5/cit5) 2004; 38
Elferink M. (ref9/cit9) 2008; 229
Meier P. (ref31/cit31) 1990; 120
Watkins P. (ref2/cit2) 2006; 43
ref15/cit15
Todeschini R. (ref30/cit30) 2006
Tetko I. V. (ref33/cit33) 2008; 48
Downs G. (ref22/cit22) 2002; 18
Fung M. (ref1/cit1) 2009; 35
Blomme E. A. (ref11/cit11) 2009; 186
Young D. (ref18/cit18) 2008; 27
Clark R. (ref14/cit14) 2004; 22
Baskin I. (ref21/cit21) 2008; 11
Guengerich F. P. (ref29/cit29) 2007; 20
Vapnik V. N. (ref25/cit25) 2000
Cheng A. (ref13/cit13) 2003; 17
Tropsha A. (ref26/cit26) 2007; 13
References_xml – volume: 26
  start-page: 26
  issue: 2
  year: 1997
  ident: ref6/cit6
  publication-title: J. Hepatol.
  doi: 10.1016/S0168-8278(97)80494-1
– volume: 32
  start-page: 56
  year: 2000
  ident: ref17/cit17
  publication-title: Regul. Toxicol. Pharmacol.
  doi: 10.1006/rtph.2000.1399
– volume: 229
  start-page: 300
  issue: 3
  year: 2008
  ident: ref12/cit12
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/j.taap.2008.01.037
– volume: 11
  start-page: 661
  issue: 8
  year: 2008
  ident: ref21/cit21
  publication-title: Comb. Chem. High Throughput Screening
  doi: 10.2174/138620708785739907
– volume: 10
  start-page: 362
  issue: 4
  year: 2006
  ident: ref7/cit7
  publication-title: Curr. Opin. Chem. Biol.
  doi: 10.1016/j.cbpa.2006.06.023
– volume: 102
  start-page: 535
  year: 1998
  ident: ref27/cit27
  publication-title: Toxicol. Lett.
  doi: 10.1016/S0378-4274(98)00261-6
– volume: 1
  start-page: 381
  issue: 4
  year: 2004
  ident: ref3/cit3
  publication-title: Drug Discovery Today: Technol.
  doi: 10.1016/j.ddtec.2004.11.002
– volume-title: DRAGON for Windows (Software for Molecular Descriptor Calculations)
  year: 2006
  ident: ref30/cit30
– volume: 105
  start-page: 97
  issue: 1
  year: 2008
  ident: ref10/cit10
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/kfn109
– volume: 48
  start-page: 766
  issue: 4
  year: 2008
  ident: ref32/cit32
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/ci700443v
– volume: 13
  start-page: 3494
  year: 2007
  ident: ref26/cit26
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/138161207782794257
– volume: 20
  start-page: 344
  issue: 3
  year: 2007
  ident: ref29/cit29
  publication-title: Chem. Res. Toxicol.
  doi: 10.1021/tx600260a
– volume: 22
  start-page: 487
  year: 2004
  ident: ref14/cit14
  publication-title: J. Mol. Graphics Modell.
  doi: 10.1016/j.jmgm.2004.03.009
– volume-title: The Nature of Statistical Learning Theory
  year: 2000
  ident: ref25/cit25
  doi: 10.1007/978-1-4757-3264-1
– ident: ref23/cit23
– volume: 19
  start-page: 693
  year: 2006
  ident: ref19/cit19
  publication-title: J. Comput.-Aided Mol. Des.
  doi: 10.1007/s10822-005-9008-0
– volume: 27
  start-page: 1337
  year: 2008
  ident: ref18/cit18
  publication-title: QSAR Comb. Sci.
  doi: 10.1002/qsar.200810084
– volume: 120
  start-page: 221
  issue: 7
  year: 1990
  ident: ref31/cit31
  publication-title: Schweiz. Med. Wochenschr.
– volume: 6
  start-page: 111
  issue: 2
  year: 2005
  ident: ref8/cit8
  publication-title: Curr. Drug Metab.
  doi: 10.2174/1389200053586118
– volume: 32
  start-page: 56
  issue: 1
  year: 2000
  ident: ref28/cit28
  publication-title: Regul. Toxicol. Pharmacol.
  doi: 10.1006/rtph.2000.1399
– volume: 17
  start-page: 811
  year: 2003
  ident: ref13/cit13
  publication-title: J. Comput.-Aided Mol. Des.
  doi: 10.1023/B:JCAM.0000021834.50768.c6
– volume: 48
  start-page: 1733
  issue: 9
  year: 2008
  ident: ref33/cit33
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/ci800151m
– volume: 35
  start-page: 293
  year: 2009
  ident: ref1/cit1
  publication-title: Drug. Inf. J.
  doi: 10.1177/009286150103500134
– volume: 186
  start-page: 22
  issue: 1
  year: 2009
  ident: ref11/cit11
  publication-title: Toxicol. Lett.
  doi: 10.1016/j.toxlet.2008.09.017
– volume: 38
  start-page: S44
  issue: 2
  year: 2004
  ident: ref5/cit5
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/381446
– volume: 229
  start-page: 300
  year: 2008
  ident: ref9/cit9
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/j.taap.2008.01.037
– volume: 4
  start-page: 191
  issue: 3
  year: 2008
  ident: ref20/cit20
  publication-title: Curr. Comput.-Aided Drug Des.
  doi: 10.2174/157340908785747465
– ident: ref15/cit15
– volume: 29
  start-page: 533
  issue: 4
  year: 2008
  ident: ref16/cit16
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.20812
– volume: 25
  start-page: 1
  issue: 1
  year: 2007
  ident: ref24/cit24
  publication-title: Solvent Extr. Ion Exch.
  doi: 10.1080/07366290601067481
– volume: 43
  start-page: 618
  issue: 3
  year: 2006
  ident: ref2/cit2
  publication-title: Hepatology
  doi: 10.1002/hep.21095
– volume: 80
  start-page: 580
  issue: 9
  year: 2006
  ident: ref4/cit4
  publication-title: Arch. Toxicol.
  doi: 10.1007/s00204-006-0091-3
– volume: 18
  start-page: 1
  year: 2002
  ident: ref22/cit22
  publication-title: Rev. Comp. Chem.
SSID ssj0011027
Score 2.3599358
Snippet Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical...
Drug Induced Liver Injury (DILI) is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical...
SourceID pubmedcentral
proquest
pubmed
crossref
acs
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 171
SubjectTerms Animals
Chemical and Drug Induced Liver Injury
Cluster Analysis
Databases, Factual
Humans
MEDLINE
Mice
Models, Chemical
Molecular Conformation
Quantitative Structure-Activity Relationship
Title Cheminformatics Analysis of Assertions Mined from Literature That Describe Drug-Induced Liver Injury in Different Species
URI http://dx.doi.org/10.1021/tx900326k
https://www.ncbi.nlm.nih.gov/pubmed/20014752
https://www.proquest.com/docview/733805344
https://pubmed.ncbi.nlm.nih.gov/PMC2850112
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVABC
  databaseName: American Chemical Society Journals
  customDbUrl:
  eissn: 1520-5010
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011027
  issn: 0893-228X
  databaseCode: ACS
  dateStart: 19880101
  isFulltext: true
  titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals
  providerName: American Chemical Society
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fT9wwDLYYe5k0bYz9um0ga5vQHgjj0jRpHk_cEJtgQgKke6vSNGWMqYdoT9rx1-M0beEG257rpkpjJ59j-zPAx8ZFtjpn2mSaCRU5lm0byzxPSxGTpcumfdvBd7l3Ir5N4skSfPhLBJ8PP9e__WUbl-cP4CGXSvm8vdHOUR8qIKFA56kjxnky6eiDbr_qjx5bLR49d_Dkn2mRt86Z3acw7qp1QnrJ-daszrbs1V3yxn9NYQWetDgTR0ExnsGSK1dh4zAQVc838fim7qraxA08vKGwnq_C43Cbh6FI6TnMG16BsgW4tsKOywSnBY6aiL5XXzwgzJqjL1nB_Z6vmb5laiQHlzaozOH4cnbKfMcQS6L7Pi0Ev5Y_aWnxrMRx26-lxqMLR9tO9QJOdr8c7-yxtmkDM5HUNVNGJeTyCW2HPLfkniVSCas0QRsdZUVilZKFSyKzbVWWe7YZzq3UufWuXWF19BKWy2npXgOKhLCb0TZOIidyLk2RGUkOJA1MX4mGA1inVU1bo6vSJp7Oh2n_uwfwqVvw1LaU577zxq_7RN_3oheB5-M-Iey0JiUr9KEVU7rprEoVefq0nQkxgFdBifpRfNKaUDEfgFpQr17AE3wvPinPfjRE3zyJ_Wzf_G-eb-FRSGrwN0PvYLm-nLk1wkp1tt7YyjU4Nw_y
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdgPICE-BiMlY9xQmjiYR6L49jxY7UxddBOk9ZJfYscx4GxKZ2WVKL89ZztNF3HJHjOxZ939p3v7neEfPQmslEFVTpXlMvY0nxPG-pwWsoEJV348m2jYzE4418nyaSFyXG5MDiIGluqvRN_iS4QfW5-uTc3Ji7ukweJ4JEztPr7p53HAIkCqqeKKWPpZIEidPNXdwOZevUG-kutvB0deeO6OXwa6hb5gfook4vdWZPvmt-3MBz_bybPyJNW64R-YJPn5J6t1sn2SYCtnu_AeJmFVe_ANpwsAa3n6-RxeNuDkLL0gsw9ykDVqrumhgWyCUxL6Hv_vmNmGKEGW4BLYIFhh96MfekG0NzF4yq3cHA9-05d_RCDpEMXJAJH1U_caDiv4KCt3tLA6ZXFQ6h-Sc4Ov4z3B7Qt4UB1LFRDpZYpGoBcmYgVBo21VEhupEJFR8V5mRopRWnTWO8ZmRcOe4YxI1RhnKFXGhVvkLVqWtlNAjxFTU4rk6Sx5QUTusy1QHMSG8Ze4qhHtnC1s1YE68x711mUdcvdI58W-56ZFgDd1eG4vIv0Q0d6FVA_7iKCBfNkKJPO0aIrO53VmUS7Hw83znvkVeClrhUXwsZlwnpErnBZR-Dgvle_VOc_POw3SxM329f_mud78nAwHg2z4dHxtzfkUQh3cG9Gb8lacz2z71CLavItLz5_AOdxGFQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3rb9MwED_BkBAS4jFe5TFOCE18mMfqOHb8cVqpNuhGpW1Sv0WO48AYSqsllSh_PWcnzdYxCT7n4uedfee7-x3A-2AiW50zbTLNhIocy3aMZR6npYhJ0mUo33Z4JPdPxedJPGkNRZ8LQ4OoqKUqOPG9VM_yokUY6H-sf_l3Ny7Pb8OdWJKIe1Vo77jzGhBRg-ypI8Z5MlkiCV391d9Ctlq9hf5SLa9HSF65coYP4Ws32BBpcr49r7Nt-_sajuP_z-YRPGi1T9xt2OUx3HLlOmyOG_jqxRaeXGZjVVu4ieNLYOvFOtxv3viwSV16AouANlC2aq-tcIlwgtMCd4Of3zM1HpImm6NPZMFRh-JMfZkayeylYytzOLiYf2O-jogl0pEPFsGD8gdtOJ6VOGiruNR4PHN0GFVP4XT46WRvn7WlHJiJpK6ZMiohQ1Bo2-e5JaMtkUpYpUnh0VFWJFYpWbgkMjtWZbnHoOHcSp1bb_AVVkfPYK2clu4FoEhIozPaxknkRM6lKTIjyaykhqmXqN-DDVrxtBXFKg1edt5Pu-XuwYfl3qe2BUL39Th-3kT6riOdNegfNxHhkoFSkk3vcDGlm86rVJH9T4ecED143vBT14oPZRMq5j1QK5zWEXjY79Uv5dn3AP_Nk9jP9uW_5vkW7o4Hw3R0cPTlFdxroh7809FrWKsv5u4NKVN1thEk6A_kCBrX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cheminformatics+analysis+of+assertions+mined+from+literature+that+describe+drug-induced+liver+injury+in+different+species&rft.jtitle=Chemical+research+in+toxicology&rft.au=Fourches%2C+Denis&rft.au=Barnes%2C+Julie+C&rft.au=Day%2C+Nicola+C&rft.au=Bradley%2C+Paul&rft.date=2010-01-01&rft.issn=1520-5010&rft.eissn=1520-5010&rft.volume=23&rft.issue=1&rft.spage=171&rft_id=info:doi/10.1021%2Ftx900326k&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-228X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-228X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-228X&client=summon